C

Coastal Digestive Health | Maroochydore, Australia

Research site

(Unclaimed)

Location

Unit 503 5 Emporio Place, Maroochydore, Queensland, Australia

Site insights

Top conditions

Top treatments

Mirikizumab

Retatrutide

LY3437943

Etrasimod

Tilpisertib

TAK-101

EP-104IAR

Guselkumab

Golimumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 14 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Active, not recruiting

Crohn's Disease

Drug: Mirikizumab

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (DUET-UC)

The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderat...

Active, not recruiting

Colitis, Ulcerative

Biological: JNJ-78934804

Drug: Placebo

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiov...

Active, not recruiting

Obesity

Cardiovascular Diseases

Drug: Retatrutide

Drug: Placebo

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative col...

Active, not recruiting

Ulcerative Colitis

Drug: Mirikizumab

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (RESOLVE)

A Phase 1b/2 study to explore the safety, efficacy and pharmacokinetics of EP-104GI in adults with eosinophilic esophagitis (EoE). Endoscopic and his...

Enrolling

Eosinophilic Esophagitis

Drug: EP-104GI

Other: Matching vehicle control